Abstract

The signalling output of many transmembrane receptors that mediate cell-cell communication is restricted by the endosomal sorting complex required for transport (ESCRT), but the impact of this machinery on Eph tyrosine kinase receptor function is unknown. We identified the ESCRT-associated adaptor protein HD-PTP as part of an EphB2 proximity-dependent biotin identification (BioID) interactome, and confirmed this association using co-immunoprecipitation. HD-PTP loss attenuates the ephrin-B2:EphB2 signalling-induced collapse of cultured cells and axonal growth cones, and results in aberrant guidance of chick spinal motor neuron axons in vivo. HD-PTP depletion abrogates ephrin-B2-induced EphB2 clustering, and EphB2 and Src family kinase activation. HD-PTP loss also accelerates ligand-induced EphB2 degradation, contrasting the effects of HD-PTP loss on the relay of signals from other cell surface receptors. Our results link Eph function to the ESCRT machinery and demonstrate a role for HD-PTP in the earliest steps of ephrin-B:EphB signalling, as well as in obstructing premature receptor depletion.

Details

Title
The endosomal sorting adaptor HD-PTP is required for ephrin-B:EphB signalling in cellular collapse and spinal motor axon guidance
Author
Lahaie, Sylvie 1 ; Morales, Daniel 2   VIAFID ORCID Logo  ; Bagci, Halil 3 ; Hamoud, Noumeira 4 ; Charles-Etienne Castonguay 4 ; Kazan, Jalal M 5 ; Desrochers, Guillaume 5 ; Klar, Avihu 6 ; Gingras, Anne-Claude 7 ; Pause, Arnim 5 ; Côté, Jean-François 8   VIAFID ORCID Logo  ; Kania, Artur 9   VIAFID ORCID Logo 

 Institut de recherches cliniques de Montréal (IRCM), Montréal, QC, Canada; Integrated Program in Neuroscience, McGill University, Montréal, QC, Canada 
 Institut de recherches cliniques de Montréal (IRCM), Montréal, QC, Canada; Integrated Program in Neuroscience, McGill University, Montréal, QC, Canada; Neuroengineering Laboratory, Brain Mind Institute, École polytechnique fédérale de Lausanne (EPFL), Lausanne, Switzerland 
 Institut de recherches cliniques de Montréal (IRCM), Montréal, QC, Canada; Department of Anatomy and Cell Biology, McGill University, Montréal, QC, Canada 
 Institut de recherches cliniques de Montréal (IRCM), Montréal, QC, Canada 
 Goodman Cancer Research Centre, McGill University, Montréal, QC, Canada; Department of Biochemistry, McGill University, Montréal, QC, Canada 
 Department of Medical Neurobiology, IMRIC, Hebrew University-Hadassah Medical School, Jerusalem, Israel 
 Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada; Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada 
 Institut de recherches cliniques de Montréal (IRCM), Montréal, QC, Canada; Department of Anatomy and Cell Biology, McGill University, Montréal, QC, Canada; Programmes de Biologie Moléculaire, Département de Médecine, Université de Montréal, Montréal, QC, Canada; Département de Biochimie, Université de Montréal, Montréal, QC, Canada 
 Institut de recherches cliniques de Montréal (IRCM), Montréal, QC, Canada; Integrated Program in Neuroscience, McGill University, Montréal, QC, Canada; Department of Anatomy and Cell Biology, McGill University, Montréal, QC, Canada; Division of Experimental Medicine, McGill University, Montréal, QC, Canada 
Pages
1-19
Publication year
2019
Publication date
Aug 2019
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2274347811
Copyright
© 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.